Late Breaking Abstracts 2023
DOI: 10.1136/ejhpharm-2023-eahp.461
|View full text |Cite
|
Sign up to set email alerts
|

5PSQ-131 Letermovir, ganciclovir and immunoglobulins combination treatment in an immunocompromised patient with cytomegalovirus infection: a case report

Abstract: Cidofovir ILIs were prepared by diluting a vial of cidofovir 375 mg in 60 ml of 0.9% sodium chloride, obtaining a final concentration of 6.25 mg/ml. Of these 60 ml, 5 syringes of 12 ml were loaded (75 mg of cidofovir in each one), which have a stability of 5 months refrigerated (2-8°C), according previous studies.Intralesional cidofovir treatment started in February 2022. After three drug administrations, a significant improvement in lesions was described by a reduction in both their volume and extension. A ba… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles